Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 18, 2017 | Series B | $23.10M | 2 |
Boston Scientific
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Boston Scientific
|
Yes | Series B |
|
|
— | Series B |